 | Up a level |
Nendaz, M.; Spirk, D.; Kucher, Nils; Aujesky, Drahomir; Hayoz, D.; Beer, J. H.; Husmann, M.; Frauchiger, B.; Korte, W.; Wuillemin, W. A.; Jäger, K.; Righini, M.; Bounameaux, H. (2014). Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thrombosis and haemostasis, 111(3), pp. 531-538. Schattauer 10.1160/TH13-05-0427
Flammer, A.J.; T.Vo, N.T.; Ledergerber, B; Hermann, F; Gamperli, A; Huttner, A; Evison, J; Baumgartner, I; Cavassini, M; Hayoz, D.; Quitzau, K; Hersberger, M; Sudano, I; Ruschitzka, F; Luscher, T.F.; Noll, G; Weber, R. (2009). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial. Heart, 95(5), pp. 385-90. London: BMJ Publishing Group 10.1136/hrt.2007.137646
Nedeltchev, K.; Arnold, M.; Baumgartner, R.; Devuyst, G.; Erne, P.; Hayoz, D.; Sztajzel, R.; Tettenborn, B.; Mattle, H. P. (2005). Vascular risk factors in the Swiss population. Journal of neurology, 252(10), pp. 1210-1216. Springer-Medizin-Verlag 10.1007/s00415-005-0838-4
